Results 141 to 150 of about 4,433,811 (160)

Aptamers and aptamer-drug conjugates as synthetic immune modulators for cancer immunotherapy. [PDF]

open access: yesFront Immunol
Arshad F   +6 more
europepmc   +1 more source

Advances in Aptamer-Based Biosensors and Cell-Internalizing SELEX Technology for Diagnostic and Therapeutic Application

open access: yesBiosensors, 2022
Aptamers are a group of synthetic single-stranded nucleic acids. They are generated from a random library of single-stranded DNA or RNA by a technology named systematic evolution of ligands by exponential enrichment (SELEX). SELEX is a repetitive process
Muhamad Aidilfitri Mohamad Roslan   +2 more
exaly   +2 more sources

Enhanced SELEX Platforms for Aptamer Selection With Improved Characteristics: A Review

open access: yesMolecular Biotechnology
Yildirim, Nimet/0000-0002-5973-8830This review delves into the advancements in molecular recognition through enhanced SELEX (Systematic Evolution of Ligands by Exponential Enrichment) platforms and post-aptamer modifications.
Nimet Yıldırım, Veli C Ozalp
exaly   +2 more sources

Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine

open access: yesInternational Journal of Molecular Sciences, 2017
Aptamers are short DNA/RNA oligonucleotides capable of binding to target molecules with high affinity and specificity. The process of selecting an aptamer is called Systematic Evolution of Ligands by Exponential Enrichment (SELEX).
Jin Liu, Xiaohao Wu, Lü Aiping
exaly   +2 more sources
Some of the next articles are maybe not open access.

Related searches:

Capture-SELEX for Aptamer Selection: A Short Review

Talanta, 2021
Zhouping Wang, Imran Mahmood Khan
exaly  

SELEX: Critical Factors and Optimization Strategies for Successful Aptamer Selection

Biotechnology and Applied Biochemistry, 2022
Gabriele Gadermaier
exaly  

SELEX Modifications and Bioanalytical Techniques for Aptamer–Target Binding Characterization

Critical Reviews in Analytical Chemistry, 2016
Clarence M Ongkudon   +2 more
exaly  

Home - About - Disclaimer - Privacy